Who we are

Company timeline

2023

Awards

Autolus logo

Autolus named as one of The Guardian's six firms to watch in 2023.

View article

Investments

Orchard Therapeutics announces strategic financing totalling up to $188m.

View article

Spinouts

Anniversary

2022

Biopharm advancements

Blood in test tubes

BioMarin announces stable and durable annualised bleed control in the largest Phase 3 gene therapy study in adults with severe Haemophilia A.

View article
Gene therapy

Orchard Therapeutics announces historic agreement making Libmeldy available by NHS England for MLD patients.

View article
Blood samples

First gene therapy for adults with severe Haemophilia A, BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec), approved by European Commission (EC)

View article
Freeline logo

Freeline initiates dosing of second cohort in MARVEL-1 trial of FLT190 gene therapy candidate for people with Fabry disease

View article

Investments

Bramble Energy secures £35m

Series B investment round to continue its development of hydrogen fuel cells.

View article

Collaborations

IBS

Engitix announces expanded collaboration and licensing agreement with Takeda to develop new anti-fibrotic therapies in Inflammatory Bowel Disease.

View article

Spinouts

Bloomsbury Genetic Therapies logo

Bloomsbury Genetic Therapies launches with Seed financing of £5m to develop potentially curative gene therapy treatments for rare neurological and metabolic diseases.

View article

2021

Spinouts

Tunnel

UCLB spinout, Senceive, is acquired by Eddyfi/NDT.

View article
Achilles Therapeutics logo

Achilles Therapeutics announces its IPO on NASDAQ.

View article
Satalia

UCL spinout, Satalia is acquired by WPP, the world's largest advertising firm.

View article

Investments

Apollo Therapeutics Logo

Apollo Therapeutics raises £100m

Series A funding to rapidly advance cutting-edge science.

View article

Bramble Energy secures £5m

Series A investment to support the launch of its zero-emissions portable power product range.

View article

Carbon Re secures £1m

seed funding to help energy-intensive industries achieve Net Zero.

View article

Launches

Axovia Therapeutics, backed by Deerfield Management Co., launched to develop transformative medicines for ciliopathies.

View article

Awards

Anne Lane

UCLB's CEO, Anne Lane, receives a Lifetime Achievement Award in recognition of her commitment to commercialisation throughout her career.

View article
Apollo Therapeutics Logo

Apollo Therapeutics wins Praxis Auril KE Deal of the Year, for attracting major investment to empower a unique, multi-university portfolio-based biopharmaceuticals venture.

View article

Biopharm advancements

NovalGen logo

NovalGen doses its first patient in Phase I study in Chronic Lymphocytic Leukaemia and Mantle Cell Lymphoma.

View article

2020

Investments

Freeline

Freeline receives further $80m

from Syncona in its Series C funding round, to develop curative gene therapies for chronic systemic diseases.

View article

UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm.

View article

Humanloop raises funding to teach AI to learn from humans faster.

View article
UCLTF logo

UCL Technology Fund announces first close of £100m

Advancements

UCL-Ventura CPAP device.

UCL-Ventura CPAP device

UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids.

View article
Award

UCLB wins Knowledge Exchange External Initiative of the Year, for its global dissemination of the UCL-Ventura breathing aid.

View article

Social venture

Paint tube

UCL artist, Onya McCausland launches paint made from coal mine waste.

View article

Biopharm advancements

Orchard Therapeutics makes progress in its mission to help people with rare diseases.

Orchard Therapeutics logo

Orchard announces FDA-granted orphan drug designation for OTL-102 for the treatment of X-linked Chronic Granulomatous Disease.

View article

Orchard announces first patient dosed with OTL-201 gene therapy in Proof of Concept clinical trial.

View article

Spinouts

Freeline

Freeline Therapeutics makes its NASDAQ debut, raising $158.8m

Awards

Odin Vision logoechopoint-logo

Two UCLB spinout companies announced winners at the SEHTA MedTech Business Awards.

View article

2019

Social venture

UCLB social ventures video.

UCLB launches funding for early-stage social ventures.

Watch video
Help Diabetes

NHS England provides online support, developed at UCL, for type 2 diabetes.

View article

Investments

Quell Therapeutics logo

QuellTx raises £35m

Series A financing, backed by Syncona.

View article
echopoint-logo

Echopoint raises £2.8m

to address the 'grey zone' of heart disease treatment.

View article
Achilles Therapeutics logo

Achilles Therapeutics raises £100m

in oversubscribed Series B financing round.

View article

£6.5m

of funding for spinout, AstronauTx for dementia research.

View article

Announcements

Anne Lane

Dr Anne Lane appointed as new Managing Director for UCLB.

View article

Awards

Four UCLB spinout companies are named finalists in the European Lifestars Awards: Ixico, Orchard Therapeutics, Quell Therapeutics, Autolus Therapeutics.

View article

Biopharm advancements

Development of a new gene therapy for the treatment of haemophilia A, licensed to BioMarin, on track.

View article

2018

Spinouts

UCLB spinouts raise a total of $460.9m in their IPOs on NASDAQ.

Spinouts

Gene Therapy

Orchard Therapeutics acquires rare disease gene therapy portfolio from GSK.

View article

Announcements

Investments

Freeline

Freeline secures over £88m

Series B funding to drive its programmes through clinical development.

View article
Orchard Therapeutics logo

Orchard Therapeutics announces $150m

Series C financing to advance gene therapy pipeline.

View article
Logo

Engitix closes £5m

Series A financing to progress liver disease and pancreatic cancer treatment.

View article
Endomag Logo

Endomag secures $10m

Series C funding to establish better breast cancer care.

View article

Awards

Endomag Logo

UCLB spinout Endomag wins two prestigious awards: The Queen's Award for Enterprise in Innovation, Institute of Physics' British Business Innovation Award.

View article
Orchard Therapeutics logo

Orchard Therapeutics win GUV Deal of the Year Award, for its oversubscribed $110m Series B funding round.

View article

2017

Biopharm advancements

Blood test tube

BioMarin provides 1.5 years of clinical data for Valoctocogene Roxaparvovec gene therapy for severe haemophilia A, developed by Prof. Amit Nathwani, UCL Cancer Institute.

View article

First patient treated in trial of a novel liver dialysis device, DIALIVE.

View article

Investments

Research

Apollo Therapeutics launches its first four drug discovery programmes in collaboration with academics at all three partner universities, spanning a variety of disease areas and drug modalities.

View article
Orchard Therapeutics logo

Orchard Therapeutics announces $110m

Series B financing to advance transformative gene therapy pipeline.

View article
Autolus

Autolus secures $80m

Series C funding to establish clinical proof of concept for three novel haematological cancer programmes.

View article

Spinouts

Puridify

UCLB spinout company Puridify acquired by GE Healthcare.

View article

Collaborations

Chirp

UCLB spinout Chirp collaborates with Hijinx to bring toys to life.

View article

2016

Launches

logo

£50m

UCL Technology Fund launched to support academics whose research has commercial potential.

View article

£40m

Apollo Therapeutics Fund launched to drive therapeutic innovation.

View article

Advancements

Biopharm advancements

BioMarin provides positive data from its Phase 1/2 clinical trial, showing that patients with haemophilia A had improved and sustained clotting function.

View article

Investments

Achilles Therapeutics logo

Achilles Therapeutics raises £13.2m

Series A funding to develop immunotherapies for cancer.

View article
Autolus

Autolus secures £40m

Series B funding to develop its proprietary pipeline of engineered T-cell products.

View article

2015

Investments

Yaqrit receives £2m

Series A investment to deliver new treatments for liver disease.

View article
Abcodia logo

Abcodia secures £5.25m

Series B funding to help early detection of ovarian cancer.

View article
Puridify

Puridify completes £2.2m

Series A funding round for the progression of its proprietary nanofibre purification platform.

View article
MediaGamma

MediaGamma secures seed funding to bring new trading methodologies and products to the programmatic digital advertising sector.

View article

Biopharm advancements

BioMarin

BioMarin enrols first patient in Phase 1/2 trial of gene therapy drug for the treatment of haemophilia A.

View article

Spinouts

Five spinout companies launched.

Autolus

Autolus Therapeutics receives £30m

investment from Syncona.

View article
Orchard Therapeutics logo

Orchard Therapeutics secures £21m

in Series A financing led by F-Prime.

View article

Athena Vision receives $5m

investment from Kadmon Gene Therapy Holdings Ltd.

View article
Freeline

Freeline Therapeutics receive £25m

investment from Syncona.

View article

Collaborations

UCLB and Cycle Pharmaceuticals enter into partnership to repurpose drugs for liver diseases.

View article

2014

Awards

UCL Portico

UCL rated top UK university by research strength in the REF2014.

View article

Collaborations

inhealthcare

Helicon Health and Inhealthcare join forces to improve stroke prevention.

View article
BioKier

UCLB signs exclusive global licence with BioKier Inc. for treatment of metabolic diseases.

View article

Investments

Autolus

Autolus raises £30m

in Series A financing round, backed by Syncona and UCLB, for the development of cancer immunotherapies.

View article

Biopharm advancements

Eye

UCL professors working with UCLB develop a stem cell transplantation therapy which could restore sight.

View article

Social venture

Health Social Innovators Fund launches with backing from the Cabinet Office to support early-stage social ventures.

View article

Announcements

UCLB's online licensing system, e-lucid, goes live with first pilot customers.

View article